Efficacy and safety of oral weekly ibandronate in the treatment of postmenopausal osteoporosis.

Cooper, Cyrus; Emkey, Ronald D; McDonald, Robert H; Hawker, Gillian; Bianchi, Gerolamo; Wilson, Katie; Schimmer, Ralph C

Cooper, Cyrus; Emkey, Ronald D; McDonald, Robert H; Hawker, Gillian; Bianchi, Gerolamo; Wilson, Katie; Schimmer, Ralph C.

Affiliation

Cooper C; Southampton General Hospital, Medical Research Council Environmental Epidemiology Unit, Southampton, SO16 6YD United Kingdom. cc@mrc.soton.ac.uk

J Clin Endocrinol Metab ; 88(10): 4609-15, 2003 Oct.

Article in En | MEDLINE | ID: mdl-14557430

Subject(s)

Bone Density/drug effects; Diphosphonates/administration & dosage; Osteoporosis, Postmenopausal/drug therapy; Administration, Oral; Aged; Biomarkers; Diphosphonates/adverse effects; Double-Blind Method; Female; Humans; Ibandronic Acid; Lumbar Vertebrae/drug effects; Lumbar Vertebrae/metabolism; Middle Aged; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bone Density / Osteoporosis, Postmenopausal / Diphosphonates Type of study: Clinical_trials Limits: Aged / Female / Humans / Middle aged Language: En Journal: J Clin Endocrinol Metab Year: 2003 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links